Since the late 1980s, a growing body of evidence has documented that phosphoinositides and their metabolizing enzymes, which regulate a large variety of cellular functions both in the cytoplasm and at the plasma membrane, are present also within the nucleus, where they are involved in processes such as cell proliferation, differentiation, and survival. Recent studies show that nuclear Phospholipase Cb1 (a key phosphoinositide metabolizing enzyme) could be somehow involved in myelodysplastic syndromes (MDS), i.e. hematopoietic disorders that can evolve into acutemyeloid leukemia (AML). This review aims to highlight the most significant and updated findings about Phospholipase C metabolism in the nucleus under pathological conditions, namely MDS and AML.

Follo MY, Faenza I, Fiume R, Ramazzotti G, McCubrey JA, Martelli AM, et al. (2012). Revisiting nuclear phospholipase C signalling in MDS. ADVANCES IN BIOLOGICAL REGULATION, 52(1), 2-6 [10.1016/j.advenzreg.2011.09.018].

Revisiting nuclear phospholipase C signalling in MDS

FOLLO, MATILDE YUNG;FAENZA, IRENE;FIUME, ROBERTA;RAMAZZOTTI, GIULIA;MARTELLI, ALBERTO MARIA;MANZOLI, FRANCESCO ANTONIO;COCCO, LUCIO ILDEBRANDO
2012

Abstract

Since the late 1980s, a growing body of evidence has documented that phosphoinositides and their metabolizing enzymes, which regulate a large variety of cellular functions both in the cytoplasm and at the plasma membrane, are present also within the nucleus, where they are involved in processes such as cell proliferation, differentiation, and survival. Recent studies show that nuclear Phospholipase Cb1 (a key phosphoinositide metabolizing enzyme) could be somehow involved in myelodysplastic syndromes (MDS), i.e. hematopoietic disorders that can evolve into acutemyeloid leukemia (AML). This review aims to highlight the most significant and updated findings about Phospholipase C metabolism in the nucleus under pathological conditions, namely MDS and AML.
2012
Follo MY, Faenza I, Fiume R, Ramazzotti G, McCubrey JA, Martelli AM, et al. (2012). Revisiting nuclear phospholipase C signalling in MDS. ADVANCES IN BIOLOGICAL REGULATION, 52(1), 2-6 [10.1016/j.advenzreg.2011.09.018].
Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/113124
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 21
  • ???jsp.display-item.citation.isi??? ND
social impact